| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Prostacyclin receptor |
|---|
| Ligand | BDBM50101861 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_158469 |
|---|
| Ki | 750±n/a nM |
|---|
| Citation |  Maruyama, T; Asada, M; Shiraishi, T; Sakata, K; Seki, A; Yoshida, H; Shinagawa, Y; Maruyama, T; Ohuchida, S; Nakai, H; Kondo, K; Toda, M Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9beta-haloPG derivatives with improved stability. Bioorg Med Chem Lett11:2033-5 (2001) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Prostacyclin receptor |
|---|
| Name: | Prostacyclin receptor |
|---|
| Synonyms: | PGI receptor | PI2R_HUMAN | PRIPR | PTGIR | Prostacyclin (IP) Receptor | Prostacyclin receptor | Prostaglandin I | Prostaglandin I2 | Prostaglandin I2 receptor | Prostanoid IP receptor |
|---|
| Type: | G Protein-Coupled Receptor (GPCR) |
|---|
| Mol. Mass.: | 40968.22 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | The membranes prepared from human platelet were used in binding assay. |
|---|
| Residue: | 386 |
|---|
| Sequence: | MADSCRNLTYVRGSVGPATSTLMFVAGVVGNGLALGILSARRPARPSAFAVLVTGLAATD
LLGTSFLSPAVFVAYARNSSLLGLARGGPALCDAFAFAMTFFGLASMLILFAMAVERCLA
LSHPYLYAQLDGPRCARLALPAIYAFCVLFCALPLLGLGQHQQYCPGSWCFLRMRWAQPG
GAAFSLAYAGLVALLVAAIFLCNGSVTLSLCRMYRQQKRHQGSLGPRPRTGEDEVDHLIL
LALMTVVMAVCSLPLTIRCFTQAVAPDSSSEMGDLLAFRFYAFNPILDPWVFILFRKAVF
QRLKLWVCCLCLGPAHGDSQTPLSQLASGRRDPRAPSAPVGKEGSCVPLSAWGEGQVEPL
PPTQQSSGSAVGTSSKAEASVACSLC
|
|
|
|---|
| BDBM50101861 |
|---|
| n/a |
|---|
| Name | BDBM50101861 |
|---|
| Synonyms: | 4-{(S)-2-[(R)-3-Hydroxy-2-((1R,2R)-3-hydroxy-oct-1-enyl)-5-oxo-cyclopentyl]-ethylsulfanyl}-butyric acid | CHEMBL64187 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C19H32O5S |
|---|
| Mol. Mass. | 372.519 |
|---|
| SMILES | CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCSCCCC(O)=O |
|---|
| Structure | 
|
|---|
Search and Browse
